Mitogen-activated protein kinase inhibitors differently affect the growth inhibition and death of a proteasome inhibitor, MG132-treated human pulmonary fibroblast cells

Human and Experimental Toxicology

Volumn 30, Issue 12, 2011, Pages 1945-1954

  Park, Woo Hyun ^a  

^a Chonbuk National University   (South Korea)

Author keywords

Cell death; HPF; MG132; Proteasome; ROS

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; GLUTATHIONE; JANUS KINASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; REACTIVE OXYGEN METABOLITE; SMALL INTERFERING RNA;

ARTICLE; CELL DEATH; CELL GROWTH; LUNG FIBROBLAST; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; PRIORITY JOURNAL; PROTEIN DEPLETION;

APOPTOSIS; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; CYSTEINE PROTEINASE INHIBITORS; DRUG ANTAGONISM; FIBROBLASTS; GLUTATHIONE; HUMANS; LEUPEPTINS; LUNG; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA; MITOGEN-ACTIVATED PROTEIN KINASES; OXIDATIVE STRESS; OXYGEN; PROTEASOME ENDOPEPTIDASE COMPLEX; REACTIVE OXYGEN SPECIES;

EID: 84856259095     PISSN: 09603271     EISSN: 14770903     Source Type: Journal    
DOI: 10.1177/0960327111403173     Document Type: Article

References (32)

1. Orlowski RZ. The role of the ubiquitin-proteasome pathway in apoptosis. Cell Death Differ 1999; 6: 303-313. (Pubitemid 29186874)
2. Voges D, Zwickl P, and Baumeister W. The 26S proteasome: a molecular machine designed for controlled proteolysis. Ann Rev Biochem 1999; 68: 1015-1068. (Pubitemid 29449214)
3. Adams J. The proteasome: a suitable antineoplastic target. Nat Rev Cancer 2004; 4: 349-360. (Pubitemid 38579481)
4. Drexler HC. Activation of the cell death program by inhibition of proteasome function. Proc Natl Acad Sci U S A 1997; 94: 855-860. (Pubitemid 27074411)
5. Shah SA, Potter MW, and Callery MP. Ubiquitin proteasome pathway: implications and advances in cancer therapy. Surg Oncol 2001; 10: 43-52. (Pubitemid 33086839)
6. Lee DH and Goldberg AL. Proteasome inhibitors: valuable new tools for cell biologists. Trends Cell Biol 1998; 8: 397-403. (Pubitemid 28458705)
7. Wu HM, Chi KH, and Lin WW. Proteasome inhibitors stimulate activator protein-1 pathway via reactive oxygen species production. FEBS Lett 2002; 526: 101-105.
8. Perez-Galan P, et al. The proteasome inhibitor bortezomib induces apoptosis in mantle-cell lymphoma through generation of ROS and Noxa activation independent of p53 status. Blood 2006; 107: 257-264. (Pubitemid 43053550)
9. Gonzalez C, et al. Significance of ROS in oxygen sensing in cell systems with sensitivity to physiological hypoxia. Respir Physiol Neurobiol 2002; 132: 17-41. (Pubitemid 34765687)
10. Baran CP, et al. The role of ROS and RNS in regulating life and death of blood monocytes. Curr Pharm Des 2004; 10: 855-866. (Pubitemid 38380064)
11. Zelko IN, Mariani TJ, and Folz RJ. Superoxide dismutase multigene family: a comparison of the CuZn-SOD (SOD1), Mn-SOD (SOD2), and EC-SOD (SOD3) gene structures, evolution, and expression. Free Radic Biol Med 2002; 33: 337-349. (Pubitemid 34790245)
12. Wilcox CS. Reactive oxygen species: roles in blood pressure and kidney function. Curr Hypertens Rep 2002; 4: 160-166.
13. Ling YH, et al. Reactive oxygen species generation and mitochondrial dysfunction in the apoptotic response to Bortezomib, a novel proteasome inhibitor, in human H460 non-small cell lung cancer cells. J Biol Chem 2003; 278: 33714-33723.
14. Qiu JH, et al. Proteasome inhibitors induce cytochrome c-caspase-3-like protease-mediated apoptosis in cultured cortical neurons. J Neurosci 2000; 20: 259-265. (Pubitemid 30220513)
15. Genestra M. Oxyl radicals, redox-sensitive signalling cascades and antioxidants. Cell Signal 2007; 19: 1807-1819. (Pubitemid 47090178)
16. Blenis J. Signal transduction via the MAP kinases: proceed at your own RSK. Proc Natl Acad Sci U S A 1993; 90: 5889-5892. (Pubitemid 23191418)
17. Kusuhara M, et al. p38 Kinase is a negative regulator of angiotensin II signal transduction in vascular smooth muscle cells: effects on Na+/H+ exchange and ERK1/2. Circ Res 1998; 83: 824-831. (Pubitemid 28489079)
18. Hsin YH, et al. The apoptotic effect of nanosilver is mediated by a ROS-and JNK-dependent mechanism involving the mitochondrial pathway in NIH3T3 cells. Toxicol Lett 2008; 179: 130-139.
19. Mao X, et al. Induction of apoptosis by shikonin through a ROS/JNK-mediated process in Bcr/Ablpositive chronic myelogenous leukemia (CML) cells. Cell Res 2008; 18: 879-888.
20. Gomez-Lazaro M, et al. Reactive oxygen species and p38 mitogen-activated protein kinase activate Bax to induce mitochondrial cytochrome c release and apoptosis in response to malonate. Mol Pharmacol 2007; 71: 736-743. (Pubitemid 46294084)
21. Guyton KZ, et al. Activation of mitogen-activated protein kinase by H2O2. Role in cell survival following oxidant injury. J Biol Chem 1996; 271: 4138-4142.
22. Liu Y, et al. Proline oxidase activates both intrinsic and extrinsic pathways for apoptosis: the role of ROS/ superoxides, NFAT and MEK/ERK signaling. Oncogene 2006; 25: 5640-5647. (Pubitemid 44387619)
23. Henson ES and Gibson SB. Surviving cell death through epidermal growth factor (EGF) signal transduction pathways: implications for cancer therapy. Cell Signal 2006; 18: 2089-2097. (Pubitemid 44642342)
24. Han YH and Park WH. MG132 as a proteasome inhibitor induces cell growth inhibition and cell death in A549 lung cancer cells via influencing reactive oxygen species and GSH level. Hum Exp Toxicol 2010; 29: 607-614.
25. Han YH and Park WH. MG132, a proteasome inhibitor decreased the growth of Calu-6 lung cancer cells via apoptosis and GSH depletion. Toxicol In Vitro 2010; 24: 1237-1242.
26. Han YH and Park WH. Treatment with p38 inhibitor partially prevents Calu-6 lung cancer cell death by a proteasome inhibitor, MG132. Cancer Genet Cytogenet 2010; 199: 81-88.
27. Han YH, et al. The attenuation of MG132, a proteasome inhibitor, induced A549 lung cancer cell death by p38 inhibitor in ROS-independent manner. Oncol Res 2010; 18: 315-322.
28. Han YH, et al. JNK and p38 inhibitors increase and decrease apoptosis, respectively, in pyrogallol-treated calf pulmonary arterial endothelial cells. Int J Mol Med 2009; 24: 717-722.
29. Park WH, et al. Arsenic trioxide-mediated growth inhibition in MC/CAR myeloma cells via cell cycle arrest in association with induction of cyclin-dependent kinase inhibitor, p21, and apoptosis. Cancer Res 2000; 60: 3065-3071. (Pubitemid 30395836)
30. Han YH, et al. Arsenic trioxide inhibits growth of As4.1 juxtaglomerular cells via cell cycle arrest and caspase-independent apoptosis. Am J Physiol Renal Physiol 2007; 293: F511-F520. (Pubitemid 47364623)
31. Han YH, et al. Pyrogallol as a glutathione depletor induces apoptosis in HeLa cells. Int J Mol Med 2008; 21: 721-730.
32. Elbashir SM, et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001; 411: 494-498. (Pubitemid 32494397)